查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425011

抗逆转录病毒药物市场，按产品类型、按应用、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Anti-retroviral Drugs Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 291 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年抗爱滋病毒药物市场规模为397.942亿美元，2023年至2030年复合CAGR为5.1%。

抗逆转录病毒药物市场-市场动态

爱滋病毒负担的增加、研发投资的增加以及更有效的新药的出现预计将推动市场需求

分析市场的成长受到几个关键因素的推动，包括爱滋病毒负担的增加、研发 (R&D) 投资的增加以及更有效的新药的出现。例如，2022 年，印度爱滋病毒估计情况说明书报告称，2021 年每年新增感染病例(ANI) 估计为62970 例。此外，世界卫生组织(WHO) 于2022 年7 月报告称，印度有3840 万人感染爱滋病毒。2021 年。非洲地区仍受到严重影响，大约每 25 名成年人中就有 1 人 (3.4%) 感染爱滋病毒，占全球爱滋病毒感染人口的三分之二以上。世卫组织也强调，过去 20 年来，爱滋病毒病例显着增加了 32.8%。因此，爱滋病毒流行率的不断上升刺激了对抗逆转录病毒药物的需求。

此外，各製药公司加大研发投入是市场成长的动力。例如，2022 年 6 月，GSK（葛兰素史克）宣布巨额投资 10 亿欧元，旨在加速治疗传染病的研发活动，特别是那些对低收入国家影响尤为严重的传染病。 GSK 的研究重点是开发新型创新疫苗和药物，以预防和治疗各种疾病，包括爱滋病毒（透过 ViiV Healthcare）、疟疾、结核病和其他传染病。这些疾病总共占许多低收入国家疾病负担的 60% 以上。 GSK 的全球健康研发中心正在推动 30 多种潜在的新疫苗和药物，针对 13 种高负担传染病，包括抗逆转录病毒药物研究。因此，增加研发投资是研究市场扩张的重要驱动因素。

抗逆转录病毒药物市场-关键见解

根据我们的研究分析师分享的分析，预计全球抗逆转录病毒药物市场在预测期内（2023-2030）每年将以 5.1% 左右的CAGR成长

由于爱滋病毒负担的增加、研发 (R&D) 投资的增加以及更有效的新药的出现，抗逆转录病毒药物市场预计将以显着的速度增长

根据产品类型，核苷逆转录酶抑制剂 (NRTI) 和非核苷逆转录酶抑制剂 (NNRTI) 预计将在 2022 年占据最大市场份额

根据应用情况，爱滋病毒/爱滋病是 2022 年的主要细分市场

按地区划分，北美是 2022 年的主要收入来源

抗逆转录病毒药物市场-細項分析：

全球抗逆转录病毒药物市场根据产品类型、按应用和地区进行细分。

根据产品类型，市场分为四个部分：蛋白酶抑制剂、非核苷逆转录酶抑制剂、整合酶抑制剂、核苷类似物和核苷逆转录酶抑制剂。在此分类中，核苷逆转录酶抑制剂 (NRTI) 和非核苷逆转录酶抑制剂 (NNRTI) 脱颖而出，为该细分市场提供了巨大的成长潜力。 NRTI 透过阻断逆转录酶发挥作用，而 NNRTI 则与逆转录酶结合併随后修饰逆转录酶。这种双重机制干扰了爱滋病毒自我复製所需的酶，使得这两种类型在对抗病毒方面特别有效。

此市场依应用分为四个部分：肝炎、爱滋病毒/爱滋病、疱疹、流感和其他。值得注意的是，抗爱滋病毒药物广泛用于治疗爱滋病毒/爱滋病，这主要是由于这种疾病在全球范围内的广泛流行。根据美国卫生与公众服务部的报告，全世界约有 3,720 万人正在与爱滋病毒/爱滋病作斗争。

抗逆转录病毒药物市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

抗爱滋病毒药物市场-竞争格局：

在抗爱滋病毒药物领域，公司主要专注于研究、开发和商业化。他们致力于发现和生产新的抗逆转录病毒疗法，改进现有药物，并进行临床试验以评估这些药物的安全性和有效性。此外，製药公司经常与医疗保健组织和政府机构合作，以扩大受影响地区获得抗病毒治疗的机会。

最近的发展：

2022年9月，默克宣布启动一项新的3期临床试验，以评估每日一次口服islatravir治疗HIV-1感染的疗效。

2022 年 8 月，吉利德 (Gilead) 的 Sunlenca (Lenacapavir) 获得了全球监管机构的批准，这是一种独特的每年两次的 HIV 治疗选择。

目录

第一章：抗爱滋病毒药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的抗爱滋病毒药物市场片段
    • 抗爱滋病毒药物市场片段（依应用）
    • 按国家/地区分類的抗逆转录病毒药物市场片段
    • 按地区分類的抗爱滋病毒药物市场片段
  • 竞争洞察

第 3 章：抗爱滋病毒药物主要市场趋势

  • 抗逆转录病毒药物市场驱动因素
    • 市场驱动因素的影响分析
  • 抗爱滋病毒药物市场限制
    • 市场限制影响分析
  • 抗爱滋病毒药物市场机会
  • 抗爱滋病毒药物市场未来趋势

第 4 章：抗爱滋病毒药物产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：抗爱滋病毒药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：抗爱滋病毒药物市场格局

  • 2022 年抗爱滋病毒药物市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：抗爱滋病毒药物市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 蛋白酶抑制剂
    • 非核苷逆转录酶抑制剂
    • 整合酶抑制剂
    • 核苷类似物和核苷逆转录酶抑制剂

第 8 章：抗爱滋病毒药物市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 肝炎
    • HIV爱滋病
    • 疱疹
    • 流感
    • 其他的

第 9 章：抗爱滋病毒药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美抗爱滋病毒药物主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲抗爱滋病毒药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区抗爱滋病毒药物主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲抗爱滋病毒药物主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲抗逆转录病毒药物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第10章：主要供应商分析-抗逆转录病毒药物产业

  • 竞争仪表板
  • 公司简介
    • AbbVie Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • F. Hoffmann-La Roche Ltd
    • Gilead Sciences, Inc.
    • Merck & Co, Inc.
    • Viatris Inc. (Mylan Inc.)
    • GlaxoSmithKline plc (ViiV Healthcare)
    • Cipla Inc.
    • Johnson and Johnson

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2211

REPORT HIGHLIGHT

Anti-retroviral Drugs Market size was valued at USD 39,794.2 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Antiretroviral drugs are medications used to treat retroviral infections, with HIV (Human Immunodeficiency Virus) being the most prominent example. These drugs work by inhibiting the replication of the virus, thereby slowing down the progression of the disease and reducing the viral load in the body.

Anti-retroviral Drugs Market- Market Dynamics

The increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs is expected to propel the market demand

The growth of the analyzed market is propelled by several key factors, including the increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs. For example, in 2022, the HIV Estimates Factsheet for India reported an estimated annual new infection (ANI) of 62.97 thousand cases in 2021. Furthermore, the World Health Organization (WHO) reported in July 2022 that 38.4 million individuals were living with HIV in 2021. The African region, in particular, remains profoundly impacted, with approximately 1 in every 25 adults (3.4%) living with HIV and contributing to over two-thirds of the global HIV-infected population. WHO also highlighted a significant 32.8% increase in HIV cases over the past two decades. Consequently, the growing prevalence of HIV is fueling the demand for antiretroviral drugs.

Moreover, increased investments in R&D by various pharmaceutical companies are a driving force behind the market's growth. As an illustration, in June 2022, GSK (GlaxoSmithKline) announced a substantial EUR 1 billion investment aimed at accelerating R&D activities for the treatment of infectious diseases, particularly those disproportionately affecting lower-income countries. GSK's research endeavors focus on the development of new and innovative vaccines and medications to prevent and treat various diseases, including HIV (via ViiV Healthcare), malaria, tuberculosis, and other infectious diseases. These diseases collectively account for over 60% of the disease burden in many lower-income nations. GSK's Global Health R&D Hubs are advancing with over 30 potential new vaccines and medications, targeting 13 high-burden infectious diseases, including antiretroviral drug research. Consequently, the augmented R&D investments are a significant driving factor behind the expansion of the studied market.

Anti-retroviral Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global Anti-retroviral Drugs Market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)

The Anti-retroviral Drugs Market is projected to grow at a significant rate driven by the increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs

Based on product type, the Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) was predicted to show maximum market share in the year 2022

Based on Application, HIV/AIDS was the leading Segment in 2022

On the basis of region, North America was the leading revenue generator in 2022

Anti-retroviral Drugs Market- Segmentation Analysis:

The Global Anti-retroviral Drugs Market is segmented on the basis of Product Type, By Application, and Region.

Based on the type of product, the market is divided into four segments: Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Integrase Inhibitors, and Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors. Within this classification, Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) stand out prominently, offering significant growth potential to this segment. NRTIs function by blocking reverse transcriptase, while NNRTIs bind to and subsequently modify reverse transcriptase. This dual mechanism interferes with the enzyme HIV requires to replicate itself, rendering these two types particularly effective in combating the virus.

The market is categorized by application into four segments: Hepatitis, HIV/AIDS, Herpes, Influenza, and Others. Notably, anti-retroviral drugs find extensive usage in the treatment of HIV/AIDS, primarily due to the substantial global prevalence of this disease. According to reports from the US Department of Health & Human Services, approximately 37.2 million individuals worldwide are grappling with HIV/AIDS.

Anti-retroviral Drugs Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Anti-retroviral Drugs Market- Competitive Landscape:

In the field of antiretroviral drugs, companies are primarily focused on research, development, and commercialization. They work on discovering and producing new antiretroviral therapies, improving existing medications, and conducting clinical trials to assess the safety and efficacy of these drugs. Additionally, pharmaceutical companies often collaborate with healthcare organizations and government agencies to expand access to antiretroviral treatments in affected regions.

Recent Developments:

In September 2022, Merck announced the commencement of a new phase 3 clinical trial to assess the efficacy of once-daily oral islatravir for the treatment of HIV-1 infection.

In August 2022, Gilead obtained global regulatory approval for Sunlenca (Lenacapavir), a unique twice-yearly treatment option for HIV.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTI-RETROVIRAL DRUGS MARKET KEY PLAYERS

  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • Merck & Co, Inc.
  • Viatris Inc. (Mylan Inc.)
  • GlaxoSmithKline plc (ViiV Healthcare)
  • Cipla Inc.
  • Johnson and Johnson

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY PRODUCT TYPE

  • Protease Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • Integrase Inhibitors
  • Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY APPLICATION

  • Hepatitis
  • HIV/AIDS
  • Herpes
  • Influenza
  • Others

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Anti-retroviral Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Anti-retroviral Drugs Market Snippet by Product Type
    • 2.1.2. Anti-retroviral Drugs Market Snippet by Application
    • 2.1.3. Anti-retroviral Drugs Market Snippet by Country
    • 2.1.4. Anti-retroviral Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Anti-retroviral Drugs Key Market Trends

  • 3.1. Anti-retroviral Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Anti-retroviral Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Anti-retroviral Drugs Market Opportunities
  • 3.4. Anti-retroviral Drugs Market Future Trends

4. Anti-retroviral Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Anti-retroviral Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Anti-retroviral Drugs Market Landscape

  • 6.1. Anti-retroviral Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Anti-retroviral Drugs Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Protease Inhibitors
    • 7.1.3. Non-Nucleoside Reverse Transcriptase Inhibitors
    • 7.1.4. Integrase Inhibitors
    • 7.1.5. Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

8. Anti-retroviral Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hepatitis
    • 8.1.3. HIV/AIDS
    • 8.1.4. Herpes
    • 8.1.5. Influenza
    • 8.1.6. Others

9. Anti-retroviral Drugs Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Anti-retroviral Drugs Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Anti-retroviral Drugs Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Anti-retroviral Drugs Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Anti-retroviral Drugs Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Anti-retroviral Drugs Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Anti-retroviral Drugs Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. AbbVie Inc.
    • 10.2.2. Boehringer Ingelheim International GmbH
    • 10.2.3. Bristol-Myers Squibb Company
    • 10.2.4. F. Hoffmann-La Roche Ltd
    • 10.2.5. Gilead Sciences, Inc.
    • 10.2.6. Merck & Co, Inc.
    • 10.2.7. Viatris Inc. (Mylan Inc.)
    • 10.2.8. GlaxoSmithKline plc (ViiV Healthcare)
    • 10.2.9. Cipla Inc.
    • 10.2.10. Johnson and Johnson

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Anti-retroviral Drugs Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Anti-retroviral Drugs Market, by Product Type 2018-2030 (USD Million)
  • TABLE Anti-retroviral Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Anti-retroviral Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Anti-retroviral Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Anti-retroviral Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Anti-retroviral Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Europe Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Latin America Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Germany Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE India Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Brazil Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)